Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
349 GBX | +1.16% | -6.93% | -0.99% |
05-22 | MaxCyte inks deal with Legend Biotech for tech supply | AN |
05-22 | MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.99% | 461M | |
+7.32% | 217B | |
+13.83% | 195B | |
+31.33% | 112B | |
+3.65% | 65.83B | |
+14.64% | 52.67B | |
+2.72% | 49.86B | |
-5.88% | 38.18B | |
+0.25% | 35.39B | |
+22.76% | 31.02B |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- Cell Engineering Company MaxCyte Appoints New CFO